Sertaconazole nitrate (Ertaczo, Dermofix, Konzert, and Zalain) is a topical broad-spectrum antifungal medication of the imidazole class.

APX001A (Manogepix, E1210) is a first-in-class, broad-spectrum and orally bioactive inhibitor of the fungal protein Gwt1 (GPI-anchored wall transfer protein 1) in the glycosylphosphatidylinositol (GPI) biosynthesis pathway.

Hexetidine (NSC17764; NSC-17764) is a potent anti-bacterial and anti-fungal agent commonly used in both veterinary and human medicine.

Tavaborole (formerly known as AN-2690; AN2690; trade name Kerydin) is a topical antifungal medication approved by the US FDA in July 2014 for the treatment of onychomycosis, which is a fungal infection of the nail and nail bed.

Tubercidin (7-Deazaadenosine), an antibiotic isolated from Streptomyces tubercidicus, is a DNA/RNA Synthesis inhibitor.

Tioconazole (formerly known as UK-20349) is a potent imidazole-based antifungal medication that has been approved for the treatment of infections caused by a fungus or yeast.

Tolnaftate (formerly NP-27; trade names: Tinactin, Tinaderm, Aftate) is a synthetic thiocarbamate used as an anti-fungal agent that may be sold as an OTC drug.

Butoconazole Nitrate (RS-35887) is a synthetic imidazole analog with fungistatic/antifungal properties.

Efinaconazole(formerly AGJ-95634; KP-103; CTK-5J2975; KB-145948; trade names Jublia; Clenafin) is a triazole antifungal drug approved for use in various countries such as the United States, Canada, and Japan as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nails).

Flucytosine (also known as 5-Fluorocytosine, 5-FC, Ancobon), a fluorinated pyrimidine analogue, is a potent and oral antifungal drug that is structurally related to the cytostatic fluorouracil and to floxuridine.